Matches in SemOpenAlex for { <https://semopenalex.org/work/W4362486019> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- W4362486019 abstract "<div>Abstract<p>Emotional stress activates the sympathetic nervous system (SNS) and release of the neurotransmitter norepinephrine to promote breast tumor pathogenesis. We demonstrate here that the metastatic mammary adenocarcinoma cell line 4T1 does not express functional adrenergic receptors (AR), the receptors activated by norepinephrine, yet stimulation of adrenergic receptor <i>in vivo</i> altered 4T1 tumor progression <i>in vivo</i>. Chronic treatment with the antidepressant desipramine (DMI) to inhibit norepinephrine reuptake increased 4T1 tumor growth but not metastasis. Treatment with a highly selective α<sub>2</sub>-adrenergic receptor agonist, dexmedetomidine (DEX), increased tumor growth and metastasis. Neither isoproterenol (ISO), a β-AR agonist, nor phenylephrine, an α<sub>1</sub>-AR agonist, altered tumor growth or metastasis. Neither DMI- nor DEX-induced tumor growth was associated with increased angiogenesis. In DMI-treated mice, tumor VEGF, IL-6, and the prometastatic chemokines RANTES, M-CSF, and MIP-2 were reduced. Tumor collagen microstructure was examined using second harmonic generation (SHG), a nonabsorptive optical scattering process to highlight fibrillar collagen. In DMI- and DEX-treated mice, but not ISO-treated mice, tumor SHG was significantly altered without changing fibrillar collagen content, as detected by immunofluorescence. These results demonstrate that α<sub>2</sub>-AR activation can promote tumor progression in the absence of direct sympathetic input to breast tumor cells. The results also suggest that SNS activation may regulate tumor progression through alterations in the extracellular matrix, with outcome dependent on the combination of adrenergic receptor activated. These results underscore the complexities underlying SNS regulation of breast tumor pathogenesis, and suggest that the therapeutic use of adrenergic receptor blockers, tricyclic antidepressants, and adrenergic receptor agonists must be approached cautiously in patients with breast cancer. <i>Cancer Prev Res; 6(12); 1262–72. ©2013 AACR</i>.</p></div>" @default.
- W4362486019 created "2023-04-05" @default.
- W4362486019 creator A5045357714 @default.
- W4362486019 creator A5047492118 @default.
- W4362486019 creator A5049800878 @default.
- W4362486019 creator A5054293477 @default.
- W4362486019 creator A5065531168 @default.
- W4362486019 date "2023-04-03" @default.
- W4362486019 modified "2023-09-26" @default.
- W4362486019 title "Data from The Antidepressant Desipramine and α<sub>2</sub>-Adrenergic Receptor Activation Promote Breast Tumor Progression in Association with Altered Collagen Structure" @default.
- W4362486019 doi "https://doi.org/10.1158/1940-6207.c.6544250" @default.
- W4362486019 hasPublicationYear "2023" @default.
- W4362486019 type Work @default.
- W4362486019 citedByCount "0" @default.
- W4362486019 crossrefType "posted-content" @default.
- W4362486019 hasAuthorship W4362486019A5045357714 @default.
- W4362486019 hasAuthorship W4362486019A5047492118 @default.
- W4362486019 hasAuthorship W4362486019A5049800878 @default.
- W4362486019 hasAuthorship W4362486019A5054293477 @default.
- W4362486019 hasAuthorship W4362486019A5065531168 @default.
- W4362486019 hasConcept C121608353 @default.
- W4362486019 hasConcept C126322002 @default.
- W4362486019 hasConcept C134018914 @default.
- W4362486019 hasConcept C170493617 @default.
- W4362486019 hasConcept C185592680 @default.
- W4362486019 hasConcept C2776187077 @default.
- W4362486019 hasConcept C2778938600 @default.
- W4362486019 hasConcept C2779177272 @default.
- W4362486019 hasConcept C2779256057 @default.
- W4362486019 hasConcept C2780250439 @default.
- W4362486019 hasConcept C2780394083 @default.
- W4362486019 hasConcept C2781161787 @default.
- W4362486019 hasConcept C502942594 @default.
- W4362486019 hasConcept C530470458 @default.
- W4362486019 hasConcept C71924100 @default.
- W4362486019 hasConcept C86803240 @default.
- W4362486019 hasConceptScore W4362486019C121608353 @default.
- W4362486019 hasConceptScore W4362486019C126322002 @default.
- W4362486019 hasConceptScore W4362486019C134018914 @default.
- W4362486019 hasConceptScore W4362486019C170493617 @default.
- W4362486019 hasConceptScore W4362486019C185592680 @default.
- W4362486019 hasConceptScore W4362486019C2776187077 @default.
- W4362486019 hasConceptScore W4362486019C2778938600 @default.
- W4362486019 hasConceptScore W4362486019C2779177272 @default.
- W4362486019 hasConceptScore W4362486019C2779256057 @default.
- W4362486019 hasConceptScore W4362486019C2780250439 @default.
- W4362486019 hasConceptScore W4362486019C2780394083 @default.
- W4362486019 hasConceptScore W4362486019C2781161787 @default.
- W4362486019 hasConceptScore W4362486019C502942594 @default.
- W4362486019 hasConceptScore W4362486019C530470458 @default.
- W4362486019 hasConceptScore W4362486019C71924100 @default.
- W4362486019 hasConceptScore W4362486019C86803240 @default.
- W4362486019 hasLocation W43624860191 @default.
- W4362486019 hasOpenAccess W4362486019 @default.
- W4362486019 hasPrimaryLocation W43624860191 @default.
- W4362486019 hasRelatedWork W2011674713 @default.
- W4362486019 hasRelatedWork W2020574893 @default.
- W4362486019 hasRelatedWork W2027913950 @default.
- W4362486019 hasRelatedWork W2034583712 @default.
- W4362486019 hasRelatedWork W2050423574 @default.
- W4362486019 hasRelatedWork W2063619316 @default.
- W4362486019 hasRelatedWork W2074821979 @default.
- W4362486019 hasRelatedWork W2077993809 @default.
- W4362486019 hasRelatedWork W2101411396 @default.
- W4362486019 hasRelatedWork W2169225653 @default.
- W4362486019 isParatext "false" @default.
- W4362486019 isRetracted "false" @default.
- W4362486019 workType "article" @default.